-
Keyue Pharmaceuticals will report the latest preclinical data of its lead project KP104 at the 18th European Conference on Complement and Human Disease
Time of Update: 2022-09-09
Oral presentation at the congress on the favorable pharmacokinetic and pharmacodynamic properties of intravenous and subcutaneous administration of KP104 in relevant animal models, supporting further
-
Medical device companies have announced their first quarterly reports, and many companies' net profit has risen sharply
Time of Update: 2022-05-14
According to data, from 2014 to 2020, China's medical device market has achieved a growth of 500 billion yuan .
18%; the net profit attributable to shareholders of listed companies is 8 billion yuan, a year-on-year increase of 20.
-
Since 2022, these pharmaceutical stocks have increased significantly
Time of Update: 2022-04-16
Data shows that in 2019, Asia Pacific Pharmaceuticals lost more than 2 billion yuan; in 2020, its net profit increased by 101.
It is reported that the continuous daily limit of Kaikai Industrial's share price is closely related to recent market rumors that its wholly-owned subsidiary Shanghai Leiyunshang Pharmaceutical West Co.
-
"Learning both internally and externally to talk about sugar control"-To improve the quality of life and prolong lifespan, how to optimize the insulin treatment plan for elderly patients with T2DM
Time of Update: 2022-01-10
Director Chen Lei, Suzhou Municipal Hospital: The case described in this issue is an elderly T2DM patient with poor blood glucose control with premixed insulin, combined with diabetic retinopathy, hypertension grade 2 (very high risk), coronary heart disease, atrial fibrillation, and blood glucose levels that are not up to standard In addition, there are large fluctuations, high fasting blood glucose and postprandial blood glucose, and poor compliance.
-
J Neuroinflammation: After COVID-19 infection, brain injury, endothelial injury and inflammation markers are elevated and show specific changes in gender
Time of Update: 2021-12-25
Results: In the new coronary pneumonia group, 3 BIM MAP2, NSE and S100B, 2 EIM sICAM 1 and sVCAM1 and 7 CCs Gro IL 10, sCD40L, IP10, IL 1ra, MCP1 and TNFα were significantly higher than those in the control group (P<0.
-
Science Sub-Journal: Snake Venom that Saves Life
Time of Update: 2021-07-29
Kibret Mequanint is not particularly fond of these slippery reptiles (in fact, he also hates them), but this Western University bioengineer and his international collaborators have discovered a new use of snake venom: a kind of human tissue.
-
These drugs will be "prescription outflow" and another province will start pilot projects
Time of Update: 2021-06-23
The Hunan Provincial Health Commission requires relevant medical institutions to complete the interface upgrade and transformation of the institution's HIS system as required, complete the docking with the prescription circulation and supervision platform, and realize the functions of real-time upload of prescription information and electronic signature and certification of physicians and pharmacists .
-
DOAC is better than warfarin in preventing stroke in patients with valvular atrial fibrillation
Time of Update: 2021-05-09
However, later trials included more patients with valvular atrial fibrillation, and recent studies only excluded patients with mechanical valves and moderate to severe mitral stenosis.
Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with valvular atrial fibrillation: A population-based cohort study.
-
What are the benefits of paying employer liability insurance for companies and how are the benefits paid
Time of Update: 2021-04-29
Employer’s liability insurance can be responsible for the following expenses not covered by the work-related injury coordination insurance: hospitalized meal subsidies, transportation for seeking medical care outside the overall planning area, food and lodging, and nursing expenses required during the period when the injured brother became a big brother.
-
Hubei phased out the medical supplies plus
Time of Update: 2021-02-22
The increase in the price of medical services shall be paid in accordance with the provisions of the basic medical insurance policy and will not increase the burden of personal medical expenses of the insured persons in general.
-
Liaoning Health and Health Commission to crack down on fraud
Time of Update: 2021-02-19
Recently, the Liaoning Provincial Health and Health Commission issued the "Work Programme on the Implementation of the Provincial Government's Special Action to Combat Medical Insurance Fraud and Insurance Standards for Diagnosis and Treatment", which explicitly used a month and a half to focus on the province's designated medical institutions to carry out special actions, to examine the use of medical insurance funds and medical services, and to urge medical institutions to practise strictly in accordance with the law.
-
Nanjing deepens medical reform and promotes three steps of graded diagnosis and treatment
Time of Update: 2021-02-05
At the same time, the Nanjing area of the second and third-level hospitals 30% of the expert number source, a week in advance to the city's primary medical institutions family doctors open.
-
Fund rankings have changed significantly since August, with some pharmaceutical-themed funds falling
Time of Update: 2020-11-19
From the ranking situation, the top 10 are the Great Wall environmental theme mix, the Great Wall long-term mixed, the integration of the health care industry mix, Guangfa new economic mix, the integration of the health industry flexible configuration mix, China Merchants Pharmaceutical and Health industry stocks, Guangfa high-end manufacturing stocks, ICBC frontier medical stocks, Tianhong Medical Health Hybrid A and NORD value advantage mix.
-
3 billion antihypertensive drug big varieties to meet the first evaluation of the original research drug "lost" 70% of the market
Time of Update: 2020-06-01
The basic situation of medicine the original development agent of the boson capsule (80mg) for novartis "devin" of Switzerland, the indications for the treatment of light and moderate primary hyperte
-
Medical device sector last year fruitful three major investment main line exposure
Time of Update: 2020-05-13
, net profit has all increased, both in scale and at a considerable rate overall solid growthin From the disclosed transcripts, the performance of pharmaceutical companies in 2013 basically contin
